Buy-side financial due diligence in upper middle market acquisitions most frequently finds three things that were not in the seller's representations: EBITDA that does not survive normalization at the level the seller claimed, working capital that is structurally lower than the peg implied, and revenue that is less recurring than the growth story suggested. Each finding has a specific mechanism, a quantifiable deal impact, and a predictable pattern across real-economy sectors.
EBITDA normalization findings account for the largest single category of purchase price adjustment in upper middle market financial due diligence. Across upper middle market transactions, defended EBITDA typically lands 8 to 18 percent below reported EBITDA when the eight institutional adjustment categories are applied against source documentation.
The pattern is consistent across sectors:
Owner compensation. Under-market or over-market compensation adjustments surface in 60 to 75 percent of founder-owned transactions. The adjustment direction depends on the seller's tax posture. Owners minimizing personal tax exposure underpaid themselves, producing understated compensation expense and inflated EBITDA. Owners with different tax structures overpaid themselves, producing add-back opportunities the seller has already claimed.
Personal expenses. Vehicles, travel, family services, and discretionary expenses running through the operating entity surface in 50 to 65 percent of transactions. The seller's add-back schedule typically captures some but not all. Undocumented personal expenses fail institutional review.
Non-recurring items. Litigation, restructuring, one-time gains and losses claimed as non-recurring surface as findings in 40 to 55 percent of transactions. The threshold is whether the item is genuinely non-recurring. Litigation that recurs at some frequency, restructuring costs that are actually operational, and one-time items lacking documentation fail the standard.
Run-rate adjustments. Recent contract wins, price increases, and capacity additions claimed as forward-looking EBITDA fail institutional review in 70 to 85 percent of cases. The threshold is signed contracts with committed volume, not verbal indications or letters of intent.
The eight-category examination produces a defended EBITDA range that becomes the acquirer's negotiating position. On a $50M reported EBITDA transaction at an 8.0x multiple ($400M enterprise value), a 12 percent normalization finding produces $6M in EBITDA adjustment and $48M in enterprise value repricing.
Working capital diligence produces the second largest category of purchase price adjustment because sellers consistently present peg methodologies that favor cash extraction at close. The buy-side finding is not that the peg is wrong. The finding is that the peg does not reflect the capital required to operate the business.
Three patterns produce the adjustments:
TTM snapshot at favorable point. Sellers propose pegs based on trailing twelve months that include seasonal lows or cash-preservation periods. The 24-month normalized analysis reveals the actual operating requirement is higher than the peg by 10 to 25 percent of the peg amount.
Excluded definitional items. Sellers propose narrow working capital definitions that exclude customer deposits, deferred revenue, or accrued items that reduce working capital. The buy-side finding restores those items to the calculation, increasing the peg the acquirer will require.
Undisclosed seasonality. Sellers present TTM working capital without disclosing seasonal patterns. The buy-side analysis maps monthly working capital across 24 months, identifies the seasonal high and low, and normalizes to the projected close month's seasonal requirement.
The adjustment mechanics flow directly to equity value. A $50M reported peg that is $10M below normalized levels produces $10M in equity value adjustment at close. The acquirer either negotiates the peg upward pre-close or funds the working capital shortfall post-close as hidden purchase price.
Revenue quality findings restructure deal consideration more than they reprice it. When the buy-side examination finds that revenue is less recurring or less transferable than the growth story suggested, the deal typically survives, but the consideration structure changes.
The specific findings:
Customer concentration above disclosed levels. Top customer or top five revenue share higher than the CIM presented. The finding either triggers a multiple discount or shifts consideration from cash-at-close to earnout tied to customer retention.
Revenue recognition inconsistency. Cut-off timing, deferred revenue treatment, or milestone recognition that differs between periods. The finding requires normalization that reduces reported revenue in certain periods, affecting trailing growth calculations.
Contract terms less favorable than represented. Customer contracts with termination clauses, price adjustment mechanisms, or renewal terms less favorable than the seller represented. The finding shifts recurring revenue characterization to transactional, reducing the multiple applied.
Growth attribution errors. Growth attributed to specific initiatives (pricing, new customers, expanded services) that examination reveals was driven by different factors (one-time projects, price increases from single customers, non-recurring events).
Deal consideration adjustments respond differently to revenue quality findings than to EBITDA findings. EBITDA findings produce cash price reductions. Revenue quality findings produce structural changes: earnout components, seller notes tied to retention, escrow arrangements for indemnification.
Balance sheet findings do not typically reprice deals at close. They surface post-close as liabilities the acquirer did not underwrite. The buy-side examination addresses them through representations and warranties, indemnification structures, and escrow arrangements.
| Finding Category | Frequency In Upper Middle Market | Typical Adjustment Range | Structure Response |
|---|---|---|---|
| Deferred revenue undisclosed | 35–50% | $2M–$15M | Working capital adjustment or reserve |
| Contingent liabilities (litigation, warranty) | 40–60% | $1M–$20M | Escrow, R&W insurance, specific indemnity |
| Capex misclassified as opex | 45–55% | $2M–$10M EBITDA | Direct EBITDA adjustment |
| Related party balances at non-arm's length | 30–45% | $1M–$8M | Pre-close settlement or adjustment |
| Environmental or regulatory exposure | 15–30% (sector-dependent) | $5M–$50M+ | Specific indemnity, insurance, escrow |
| Inventory obsolescence undisclosed | 40–55% (product businesses) | $2M–$12M | Working capital adjustment or reserve |
| AR aging beyond disclosed | 50–65% | $1M–$8M | Working capital adjustment |
| Accrued expenses understated | 40–55% | $1M–$6M | EBITDA adjustment |
Balance sheet findings drive the structure of the definitive agreement more than they drive purchase price. Representations and warranties, indemnification caps, escrow amounts, and R&W insurance coverage are all calibrated to the findings the buy-side examination produced.
FDD findings produce four distinct deal responses depending on the finding category and severity:
Findings that produce quantifiable, defensible EBITDA or working capital adjustments translate directly into purchase price. The buy-side team produces the schedule, the seller reviews and negotiates specific items, and the parties agree on the adjustment.
The distinction between findings that reprice deals and findings that kill deals is the ratio of finding to reported metric. Small findings reprice. Large findings restructure. Findings that undermine the thesis kill deals.
Buy-side FDD executes within Layer 3 of the Buy-Side Advisory five-layer architecture. The Financial Truth Ladder governs how EBITDA defensibility is positioned. The Reporting Under Scrutiny Model governs how financial information is examined across five layers.
Buy-side financial due diligence exists to find what the seller's representations did not disclose. The eight adjustment categories, working capital normalization, and balance sheet examination produce the defended position the acquirer negotiates from.